维普中文期刊产品整合服务
15篇 您的检索式:作者名="Panagakis G"
    题名 作者 年代 出处 被引量
1Lcaarnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine deficient hearts显示文摘Broderick TL Panagakis G DiDomenico D 1995Cardiovasc Res1995,30,:1
2L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts 显示文摘Broderick TL Panagakis G DiDomenico D 1995Cardiovasc Res1995,30,:1
3Nonnegative muhilinear principal component analysis of auditory tem- poral modulations for music genre classification 显示文摘Panagakis Y Kotropoulos C Arce G R 2010Au- dio Speech and Language Processing2010,18,3:1
4L-camitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in camitine-deficient hearts显示文摘Broderick TL Panagakis G DiDomenico D 1995Cardiovascular Research1995,30,5:1
5Visual and motphological outcomes of bevacizumab (Avastin) versus ranibizumab (Lucontis) treatment for retinal angiomatous proliferation显示文摘Hufendiek K Hufendiek K Panagakis G 2012Int Ophthalmol2012,32,3:1
6L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts显示文摘Broderick TL Panagakis G DiDomenico D 1995Cardiovasc Res1995,30,5:1
7Visual and mor- phological outcomes of bevacizumab (Avastin) versus ranibizum- ab (lucentis) treatment for retinal angiomatous proliferation 显示文摘Hufendiek K Hufendiek K Panagakis G 2012Int Ophthalmol2012,32,3:1
8L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts显示文摘BRODERICK T L PANAGAKIS G DIDOMENICO D 1995Cardiovasc Res1995,30,5:1
9Effects on choroidal neo-vascularization after anti-VEGF upload using intravitreal ranibi-zumab, as determined by spectral domain-optical coherencetomography显示文摘Framme C Panagakis G Bimgruber R 2010Invest Ophthalmol Vis 5ci2010,51,3:1
10Visual and mor- phological outcomes of bevacizumab(Avastin~)versus ranibizumab (Lucentis) treatment for retinal angiomatous proliferation 显示文摘Hufendiek K Hufendiek K Panagakis G 2012Int Ophthalmol2012,32,3:1
11Non-nega-tive Multilinear Principal Component Analysis of Auditory Temporal Modulations for Music Genre Classification显示文摘Panagakis Y Kotropoulos C Arce G R 2010Audio Speech and Language Processing2010,18,3:1
12Visual and morphologi- cal outcomes of bevacizmnab (Avasfin @versus ranibizumab (Lucentis @) treatment for retinal angiomatous prelifemtion显示文摘Hufendiek K Hufendiek K Panagakis G 2012Int Ophthalmol2012,32,3:1
13Nonnegative multilinear principal component analysis of auditory temporal modulations for music genre classification显示文摘PANAGAKIS Y KOTROPOULOS C ARCE G R 2010IEEE Transactions on Audio Speech and Language Processing2010,,18:1
14Visual and morphological outcomes of bevacizumab (Avastin) versus ranibizumab(Lucentis) treatment for retinal angiomatous proliferation显示文摘Hufendiek K Hufendiek K Panagakis G 0,,03:1
15Predictive fac-tors in OCT analysis for visual outcome in exudative AMD显示文摘Gamulescu MA Panagakis G Theek C Helbig H 2012JOphthalmol2012,2012,85:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费